We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo WHX Labs Dubai 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The model estimates when Alzheimer’s symptoms will begin based on the accumulation of amyloid and tau proteins in the brain (Photo courtesy of Sara Moser/WashU Medicine)

Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms

A single blood test model can predict Alzheimer’s symptom onset years in advance. More...
20 Feb 2026
Image: Powered by OptraSCAN’s patented OS‑SiA technology, the platform performs scanning, indexing, and AI‑driven analysis simultaneously (Photo courtesy of OptraSCAN)

New AI-Driven Platform Standardizes Tuberculosis Smear Microscopy Workflow

OptraSCAN has introduced BactoSiA, an AI-assisted tuberculosis treatment monitoring solution built to support sputum smear microscopy. More...
20 Feb 2026
Image: The model estimates when Alzheimer’s symptoms will begin based on the accumulation of amyloid and tau proteins in the brain (Photo courtesy of Sara Moser/WashU Medicine)

Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms

A single blood test model can predict Alzheimer’s symptom onset years in advance. More...
20 Feb 2026
Image: AI-powered ctDNA analysis provides clinicians with a new lens to monitor disease evolution (Photo courtesy of Brandon Stelter, Katie Han, Kyle Smith, and Paul Northcott)

AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy

An AI-driven liquid biopsy tool enhances pediatric brain tumor diagnosis. More...
19 Feb 2026
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

A new AI biomarker improves chemotherapy prediction in triple-negative breast cancer. More...
19 Feb 2026
mage: The AI-derived MYCN niche score predicts liver cancer risk before tumors form (Photo courtesy of Adobe Stock)

AI-Powered Biomarker Predicts Liver Cancer Risk

A machine-learned biomarker identifies those at high risk for liver cancer. More...
19 Feb 2026
Image: The assay evaluates tumor-derived total nucleic acid extracted from CSF and detects multiple biomarker classes (Photo courtesy of Shutterstock)

New CSF Liquid Biopsy Assay Reveals Genomic Insights for CNS Tumors

A newly validated assay enables comprehensive genomic characterization of central nervous system malignancies from cerebrospinal fluid. More...
19 Feb 2026
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Automated MALDI-TOF MS System
EXS 3000